Paper36044597
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer.
Cronin SJF and 18 others. Sci Transl Med, 2022. Cited by 44 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer. Papers, record 36044597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36044597
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Neuralgia | Major topic |
| Analgesics | |
| Animals | |
| Biopterins | |
| ErbB Receptors | |
| GTP Cyclohydrolase | |
| Humans | |
| Mice | |
| Proto-Oncogene Proteins p21(ras) |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z 271 | Austrian Science Fund FWF | Austria | PubMed | PubMed | |
| RG/F/22/110085 | British Heart Foundation | United Kingdom | PubMed | PubMed | |
| R35 NS105076 | NINDS NIH HHS | United States | R35NS105076 | PubMed and NIH | NIH RePORTER |
| CH/16/1/32013 | British Heart Foundation | United Kingdom | PubMed | PubMed | |
| R01 NS112266 | NINDS NIH HHS | United States | R01NS112266 | PubMed and NIH | NIH RePORTER |
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,712,899 | Central sensitization: a generator of pain hypersensitivity by central neural plasticity. | J Pain | 2009 | https://conductscience.org/library/papers/19712899 | PubMed |
| 2 | 32,531,343 | ErbB1-dependent signalling and vesicular trafficking in primary afferent nociceptors associated with hypersensitivity in neuropathic pain. | Neurobiol Dis | 2020 | https://conductscience.org/library/papers/32531343 | PubMed |
| 3 | 17,343,757 | Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans. | Mol Pain | 2007 | https://conductscience.org/library/papers/17343757 | PubMed |
| 4 | 11,751,630 | Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. | Genes Dev | 2001 | https://conductscience.org/library/papers/11751630 | PubMed |
| 5 | 27,445,601 | Treating Chronic Pain with SSRIs: What Do We Know? | Pain Res Manag | 2016 | https://conductscience.org/library/papers/27445601 | PubMed |
| 6 | 20,838,263 | Polymorphic variation of the guanosine triphosphate cyclohydrolase 1 gene predicts outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. | Spine (Phila Pa 1976) | 2010 | https://conductscience.org/library/papers/20838263 | PubMed |
| 7 | 26,590,256 | STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26590256 | PubMed |
| 8 | 4,623,662 | Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies. | Neuropharmacology | 1972 | https://conductscience.org/library/papers/4623662 | PubMed |
| 9 | 12,509,763 | Targeting RAS signalling pathways in cancer therapy. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12509763 | PubMed |
| 10 | 29,844,152 | Endothelial Cell Tetrahydrobiopterin Modulates Sensitivity to Ang (Angiotensin) II-Induced Vascular Remodeling, Blood Pressure, and Abdominal Aortic Aneurysm. | Hypertension | 2018 | https://conductscience.org/library/papers/29844152 | PubMed |
| 11 | 30,405,245 | The metabolite BH4 controls T cell proliferation in autoimmunity and cancer. | Nature | 2018 | https://conductscience.org/library/papers/30405245 | PubMed |
| 12 | 9,190,882 | Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor. | J Pharmacol Exp Ther | 1997 | https://conductscience.org/library/papers/9190882 | PubMed |
| 13 | 25,783,971 | Evidence of a role for GTP cyclohydrolase-1 in visceral pain. | Neurogastroenterol Motil | 2015 | https://conductscience.org/library/papers/25783971 | PubMed |
| 14 | 22,707,700 | Cetuximab alleviates neuropathic pain despite tumour progression. | BMJ Case Rep | 2012 | https://conductscience.org/library/papers/22707700 | PubMed |
| 15 | 33,042,327 | The knockdown of the sepiapterin reductase gene suppresses the proliferation of breast cancer by inducing ROS-mediated apoptosis. | Int J Clin Exp Pathol | 2020 | https://conductscience.org/library/papers/33042327 | PubMed |
| 16 | 16,095,934 | Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. | Eur J Pain | 2006 | https://conductscience.org/library/papers/16095934 | PubMed |
| 17 | 29,893,410 | Fluphenazine (oral) versus placebo for schizophrenia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29893410 | PubMed |
| 18 | 26,236,660 | Evaluating the Anti-nociceptive and Anti-inflammatory Effects of Ketotifen and Fexofenadine in Rats. | Adv Pharm Bull | 2015 | https://conductscience.org/library/papers/26236660 | PubMed |
| 19 | 29,913,682 | GCH1 variants, tetrahydrobiopterin and their effects on pain sensitivity. | Scand J Pain | 2014 | https://conductscience.org/library/papers/29913682 | PubMed |
| 20 | 25,599,448 | Association of functional variations in COMT and GCH1 genes with postherniotomy pain and related impairment. | Pain | 2015 | https://conductscience.org/library/papers/25599448 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,958,507 | Targeting tetrahydrobiopterin metabolism in diabetic neuropathic pain: mechanisms, implications, and therapeutic strategies. | J Transl Med | 2026 | https://conductscience.org/library/papers/42958507 | PubMed |
| 42,666,732 | Ferroptosis in Ischemic Stroke: Insights from Natural Product Treatment and Future Directions. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42666732 | PubMed |
| 42,198,962 | [miR-143-3p alleviates neuropathic pain in mice with spared nerve injury by targeting the KRAS/RalA pathway and inhibiting astrocyte activation]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | https://conductscience.org/library/papers/42198962 | PubMed |
| 42,183,213 | Epidermal growth factor receptor signaling modulates postoperative pain and inflammatory responses. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183213 | PubMed |
| 42,163,892 | Targeting ferroptosis in lung cancer: pharmacological regulation, nanomedicine-based delivery, and AI-enabled translational strategies. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42163892 | PubMed |
| 41,844,958 | Neuro-tumor interactions in peripheral tumors. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/41844958 | PubMed |
| 41,592,151 | EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer. | Sci Signal | 2026 | https://conductscience.org/library/papers/41592151 | PubMed |
| 41,471,274 | Ferroptosis, a Distinct Form of Cell Death, and Research Progress on Its Modulators. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471274 | PubMed |
| 41,451,225 | Utility of blood DNA methylation and immune cell-type estimates to identify clinically relevant links between immunity and health conditions in a large cohort. | Front Immunol | 2025 | https://conductscience.org/library/papers/41451225 | PubMed |
| 41,293,165 | Harnessing the gut microbiome to modulate ferroptosis: a metabolic strategy for the treatment of digestive tract cancers. | Front Immunol | 2025 | https://conductscience.org/library/papers/41293165 | PubMed |
| 41,178,527 | BH4 Oxidation-Derived H2O2 Activates ERK1/2 Signaling via B-Raf in Rat Dorsal Root Ganglion Neurons. | J Neurochem | 2025 | https://conductscience.org/library/papers/41178527 | PubMed |
| 41,111,418 | ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury. | Circulation | 2026 | https://conductscience.org/library/papers/41111418 | PubMed |
| 40,331,198 | Gaussian white noise stimulation as an alternative method to excite sensory neurons. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40331198 | PubMed |
| 40,143,150 | Gambogenic Acid Suppresses Malignant Progression of Non-Small Cell Lung Cancer via GCH1-Mediated Ferroptosis. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40143150 | PubMed |
| 39,909,810 | From a clinically relevant pain target to a possible analgesic treatment strategy. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/39909810 | PubMed |
| 39,774,670 | High-Resolution Whole-Genome DNA Methylation Revealed Unique Signatures of Painful Diabetic Neuropathy. | Diabetes | 2025 | https://conductscience.org/library/papers/39774670 | PubMed |
| 39,674,763 | Cross-species RNAi therapy via AAV delivery alleviates neuropathic pain by targeting GCH1. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/39674763 | PubMed |
| 39,666,013 | Overexpression of miR-133a-3p reduces microglia activation by binding to GCH1, alleviating neuroinflammation and neuropathic pain. | Exp Brain Res | 2024 | https://conductscience.org/library/papers/39666013 | PubMed |
| 38,757,341 | Long non‑coding RNA lung cancer‑associated transcript 1 regulates ferroptosis via microRNA‑34a‑5p‑mediated GTP cyclohydrolase 1 downregulation in lung cancer cells. | Int J Oncol | 2024 | https://conductscience.org/library/papers/38757341 | PubMed |
| 38,751,681 | New role for GCH1 in cancer. | Transl Breast Cancer Res | 2024 | https://conductscience.org/library/papers/38751681 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGMO | 392,636 | PubTator's text mining | https://conductscience.org/library/genes/392636 | NCBI Gene |
| EGFR | 1,956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| GCH1 | 2,643 | PubTator's text mining | https://conductscience.org/library/genes/2643 | NCBI Gene |
| HRAS | 3,265 | PubTator's text mining | https://conductscience.org/library/genes/3265 | NCBI Gene |
| KRAS | 3,845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| NRAS | 4,893 | PubTator's text mining | https://conductscience.org/library/genes/4893 | NCBI Gene |
| PTGS2 | 5,743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36044597
GET https://conductscience.org/api/papers/v1/36044597/references?page=2